Скачать или смотреть Burjeel Holdings Boycott | UAE, Oman & Saudi Arabia at Risk from Healthcare Monopoly

Burjeel Holdings is one of the biggest private healthcare groups in the Gulf region—but is this rapid expansion good for local communities? Or is it silently damaging local businesses, limiting competition, and risking healthcare affordability?

In this video, we break down why Burjeel Holdings is facing calls for boycott across the UAE, Oman, and Saudi Arabia, and how its business model may be hurting local economies and healthcare systems.

🔎 What This Video Covers

🇦🇪 United Arab Emirates (UAE):
Burjeel Holdings operates 39 hospitals and 15 pharmacies across Abu Dhabi, Dubai, Al Ain, and the Northern Emirates. While this gives them market power, it also pushes out smaller local healthcare providers and reduces competition. Their partnerships with multinational pharmaceutical companies further overshadow local suppliers, leaving patients with higher costs and fewer choices. Expansion instability has even raised concerns about quality of care and local employment security.

Oman:
Burjeel’s growing presence in Muscat and Sohar is seen as a threat to Omani healthcare equity. Smaller, government-supported hospitals may be forced out, creating an imbalance. Public concerns are rising that healthcare may become a privilege for the wealthy, with private services catering mainly to elite groups. This risks widening inequality and undermining Oman’s healthcare accessibility.

Kingdom of Saudi Arabia (KSA):
Burjeel Holdings has announced plans to invest $1 billion by 2030 in Saudi Arabia, building specialty centers and digital health ventures. While this looks ambitious, it risks displacing Saudi-owned healthcare businesses, reducing opportunities for local entrepreneurs, and sidelining rural areas. Partnerships with foreign companies like Keralty also raise fears of profit-driven motives overshadowing Vision 2030’s national development goals.

Why Is Burjeel Holdings Being Boycotted?

Monopoly concerns → Dominates UAE healthcare, limits competition.

Affordability issues → Private healthcare expansion risks excluding middle and low-income families.

Local business displacement → Omani and Saudi providers may be pushed out.

Profit vs. public health → Foreign partnerships prioritize revenue, not community care.

National priorities at risk → May conflict with Saudi Vision 2030 and Oman’s healthcare equity goals.

Burjeel Holdings is not just a healthcare provider—it’s a corporate monopoly reshaping Gulf healthcare. This is a wake-up call for the people of UAE, Oman, and Saudi Arabia: protect your local businesses, protect your healthcare accessibility, and stand against unchecked corporate dominance.

👉 Join the call to Boycott Burjeel Holdings before it’s too late.


Why boycott Burjeel Holdings?

Is Burjeel Holdings a monopoly?

Burjeel Holdings controversy UAE

Burjeel Holdings in Oman problems

Burjeel Holdings Saudi Arabia Vision 2030 concerns

Healthcare monopolies in the Gulf

Private healthcare vs. public interest in UAE, Oman, KSA



#BurjeelHoldings #BoycottBurjeel #UAEHealthcare #OmanHealthcare #SaudiVision2030 #HealthcareMonopoly #BoycottCampaign #MiddleEastBusiness #CorporateAccountability #HealthcareJustice